Alzamend Neuro, Inc. · NASDAQ:ALZN
Alzamend Neuro, Inc. shareholders
As of Sep 30, 2026, 14 institutions reported holding Alzamend Neuro, Inc., 28.2% of its shares. Largest: Kingsbury Capital Investment Advisors LLC, Citadel and Vanguard. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Alzamend Neuro, Inc. | Change | Filed |
|---|---|---|---|---|
| Kingsbury Capital Investment Advisors LLC | 1.12M | 23.2% | −209K | Oct 20, 2026 |
| Citadel | 79,218 | 1.6% | new | Nov 16, 2026 |
| Vanguard | 57,224 | 1.2% | +28,648 | Nov 13, 2026 |
| Jane Street | 34,394 | 0.71% | new | Nov 12, 2026 |
| Hrt Financial LP | 29,272 | 0.61% | new | Nov 13, 2026 |
| Geode Capital | 26,264 | 0.54% | −107 | Nov 6, 2026 |
| State Street | 10,903 | 0.23% | new | Nov 12, 2026 |
| UBS | 3,034 | 0.06% | +682 | Nov 10, 2026 |
| Tower Research Capital LLC (TRC) | 2,227 | 0.05% | −1,290 | Nov 16, 2026 |
| BlackRock | 437 | <0.01% | no change | Nov 13, 2026 |